Related references
Note: Only part of the references are listed.Differential expression of key regulators of Toll-like receptors in ulcerative colitis and Crohn's disease: a role for Tollip and peroxisome proliferator-activated receptor gamma?
P. Fernandes et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2016)
Inflammatory impact of IFN-γ in CD8+ T cell-mediated lung injury is mediated by both Stat1-dependent and -independent pathways
Chilakamarti V. Ramana et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2015)
Safety of infliximab for the treatment of inflammatory bowel disease: current understanding of the potential for serious adverse events
Reena Khanna et al.
EXPERT OPINION ON DRUG SAFETY (2015)
Galacto-oligosaccharides Protect the Intestinal Barrier by Maintaining the Tight Junction Network and Modulating the Inflammatory Responses after a Challenge with the Mycotoxin Deoxynivalenol in Human Caco-2 Cell Mono layers and B6C3F1 Mice
Peyman Akbari et al.
JOURNAL OF NUTRITION (2015)
Lipoteichoic acid from Lactobacillus plantarum inhibits Pam2CSK4-induced IL-8 production in human intestinal epithelial cells
Su Young Noh et al.
MOLECULAR IMMUNOLOGY (2015)
GPR84 and TREM-1 Signaling Contribute to the Pathogenesis of Reflux Esophagitis
Heba Abdel-Aziz et al.
MOLECULAR MEDICINE (2015)
Extracts from peppermint leaves, lemon balm leaves and in particular angelica roots mimic the pro-secretory action of the herbal preparation STW 5 in the human intestine
Shady Allam et al.
PHYTOMEDICINE (2015)
Response to Infliximab Therapy in Ulcerative Colitis is Associated With Decreased Monocyte Activation, Reduced CCL2 Expression and Downregulation of Tenascin C
Maria K. Magnusson et al.
JOURNAL OF CROHNS & COLITIS (2015)
Anti-IP-10 antibody (BMS-936557) for ulcerative colitis: a phase II randomised study
Lloyd Mayer et al.
GUT (2014)
Curcumin and Inflammatory Bowel Disease: Potential and Limits of Innovative Treatments
Liza Vecchi Brumatti et al.
MOLECULES (2014)
Activation of Adenosine A3 Receptor Alleviates TNF-α-Induced Inflammation through Inhibition of the NF-κB Signaling Pathway in Human Colonic Epithelial Cells
Tianhua Ren et al.
MEDIATORS OF INFLAMMATION (2014)
Phytochemicals for the treatment of inflammatory bowel diseases
Mathias Jochen Schneider et al.
PHYTOCHEMISTRY REVIEWS (2014)
Influence of triterpenoids present in apple peel on inflammatory gene expression associated with inflammatory bowel disease (IBD)
Dolores Mueller et al.
FOOD CHEMISTRY (2013)
Enhanced Expression of CXCL10 in Inflammatory Bowel Disease: Potential Role of Mucosal Toll-like Receptor 3 Stimulation
Ann E. Ostvik et al.
INFLAMMATORY BOWEL DISEASES (2013)
Mechanisms of the anti-proliferative and anti-inflammatory effects of the herbal fixed combination STW 5 (Iberogast®) on colon adenocarcinoma (HT29) cells in vitro
G. A. Bonaterra et al.
PHYTOMEDICINE (2013)
NF-κB inhibition is ineffective in blocking cytokine-induced IL-8 production but P38 and STAT1 inhibitors are effective
Quan Wang et al.
INFLAMMATION RESEARCH (2012)
P2Y6 receptor contributes to neutrophil recruitment to inflamed intestinal mucosa by increasing CXC chemokine ligand 8 expression in an AP-1-dependent manner in epithelial cells
Djordje M. Grbic et al.
INFLAMMATORY BOWEL DISEASES (2012)
STW 5 is effective in dextran sulfate sodium-induced colitis in rats
Walaa Wadie et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2012)
STAT1, STAT6 and Adenosine 3′,5′-Cyclic Monophosphate (cAMP) Signaling Drive SOCS3 Expression in Inactive Ulcerative Colitis
Yi Li et al.
MOLECULAR MEDICINE (2012)
Adenosine A2A receptor contributes to the anti-inflammatory effect of the fixed herbal combination STW 5 (Iberogast®) in rat small intestinal preparations
Sebastian Michael et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2012)
Increased expression of interleukin-32 in the inflamed ileum of ankylosing spondylitis patients
Francesco Ciccia et al.
RHEUMATOLOGY (2012)
NFκB inhibitors induce cell death in glioblastomas
Alfeu Zanotto-Filho et al.
BIOCHEMICAL PHARMACOLOGY (2011)
Chemokine CXCL11 links microbial stimuli to intestinal inflammation
Z. Liu et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2011)
The role of p38 mitogen-activated protein kinase in the pathogenesis of inflammatory bowel disease
Ya Jing Feng et al.
JOURNAL OF DIGESTIVE DISEASES (2011)
MEDICAL PROGRESS Ulcerative Colitis
Silvio Danese et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
IL-8 as an important chemoattractant for neutrophils in ulcerative colitis and Crohn's disease
K. MITSUYAMA et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Effect of an Herbal Preparation, STW 5, in an Acute Model of Reflux Oesophagitis in Rats
Heba Abdel-Aziz et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2010)
Impaired activation of Stat1 and c-Jun as a possible defect in macrophages of patients with active tuberculosis
H. Esquivel-Solis et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2009)
Inhibition of inflammatory mediators by polyphenolic plant extracts in human intestinal Caco-2 cells
Beatrice Romier-Crouzet et al.
FOOD AND CHEMICAL TOXICOLOGY (2009)
MECHANISMS OF DISEASE Inflammatory Bowel Disease
Clara Abraham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Inhibition of inflammation-induced alterations in rat small intestine by the herbal preparations STW 5 and STW 6
Sebastian Michael et al.
PHYTOMEDICINE (2009)
Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: Performance of fecal lactoferrin, calprotectin, and PMN-Elastase, CRP, and clinical indices
Jost Langhorst et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Decoy oligodeoxynucleotide targeting activator protein-1 (AP-1) attenuates intestinal inflammation in murine experimental colitis
Ichiro Moriyama et al.
LABORATORY INVESTIGATION (2008)
Unravelling the pathogenesis of inflammatory bowel disease
R. J. Xavier et al.
NATURE (2007)
STW 5/Iberogast: multi-target-action for treatment of functional dyspepsia and irritable bowel syndrome
Hans-Dieter Allescher et al.
WIENER MEDIZINISCHE WOCHENSCHRIFT (2007)
Genes, diet and inflammatory bowel disease
Lynnette R. Ferguson et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2007)
Pharmaceutical prerequisites for a multi-target therapy
U. Kroll et al.
PHYTOMEDICINE (2006)
Anti-inflammatory compounds of plant origin. Part II. Modulation of pro-inflammatory cytokines, chemokines and adhesion molecules
JB Calixto et al.
PLANTA MEDICA (2004)
Glutamine and CXC chemokines IL-8, Mig, IP-10 and I-TAC in human intestinal epithelial cells
R Marion et al.
CLINICAL NUTRITION (2004)
AP-1 subunits: quarrel and harmony among siblings
J Hess et al.
JOURNAL OF CELL SCIENCE (2004)
Epidemiologic and clinical characteristics of children with newly diagnosed inflammatory bowel disease in Wisconsin: A statewide population-based study
S Kugathasan et al.
JOURNAL OF PEDIATRICS (2003)
Inhibition of interferon (IFN) γ-induced Jak-STAT1 activation in microglia by vasoactive intestinal peptide -: Inhibitory effect on CD40, IFN-induced protein-10, and inducible nitric-oxide synthase expression
M Delgado
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease
C Banks et al.
JOURNAL OF PATHOLOGY (2003)
Tumor necrosis factor signaling
H Wajant et al.
CELL DEATH AND DIFFERENTIATION (2003)
Activation of signal transducer and activator of transcription (STAT) 1 in human chronic inflammatory bowel disease
S Schreiber et al.
GUT (2002)
Inhibition of interleukin-1-stimulated MAP kinases, activating protein-1 (AP-1) and nuclear factor kappa B (NF-κB) transcription factors down-regulates matrix metalloproteinase gene expression in articular chondrocytes
A Liacini et al.
MATRIX BIOLOGY (2002)
The JNK signal transduction pathway
CR Weston et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2002)
Regulated production of interferon-inducible T-cell chemoattractants by human intestinal epithelial cells
MB Dwinell et al.
GASTROENTEROLOGY (2001)
Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity
J O'Brien et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2000)
The epidemiology and the pathogenesis of inflammatory bowel disease
K Karlinger et al.
EUROPEAN JOURNAL OF RADIOLOGY (2000)
Share Paper
